AG
NVS icon

Ascent Group’s Novartis NVS Stock Holding History

Ascent Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
12,806
-487
-4% -$73K 0.06% 267
2026
Q1 		$2.03M Buy
13,293
+173
+1% +$26.5K 0.07% 250
2025
Q4 		$1.81M Sell
13,120
-5
-0% -$655 0.06% 261
2025
Q3 		$1.68M Sell
13,125
-996
-7% -$122K 0.06% 271
2025
Q2 		$1.71M Buy
14,121
+97
+0.7% +$10.9K 0.07% 239
2025
Q1 		$1.56M Buy
14,024
+7,176
+105% +$764K 0.07% 263
2024
Q4 		$666K Buy
6,848
+157
+2% +$16.7K 0.05% 330
2024
Q3 		$770K Buy
6,691
+275
+4% +$31.2K 0.06% 318
2024
Q2 		$683K Buy
6,416
+345
+6% +$34.6K 0.06% 316
2024
Q1 		$587K Sell
6,071
-189
-3% -$19.4K 0.05% 328
2023
Q4 		$629K Sell
6,260
-289
-4% -$27.9K 0.06% 308
2023
Q3 		$611K Sell
6,549
-582
-8% -$59.1K 0.07% 291
2023
Q2 		$735K Sell
7,131
-98
-1% -$9.8K 0.08% 268
2023
Q1 		$665K Sell
7,229
-29
-0.4% -$2.53K 0.07% 275
2022
Q4 		$658K Buy
7,258
+48
+0.7% +$4.04K 0.08% 268
2022
Q3 		$585K Buy
7,210
+597
+9% +$49.5K 0.07% 268
2022
Q2 		$568K Buy
6,613
+407
+7% +$35.7K 0.07% 281
2022
Q1 		$545K Buy
6,206
+2,999
+94% +$260K 0.06% 285
2021
Q4 		$279K Buy
+3,207
New +$266K 0.04% 387

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ascent Group's NVS Position: Q2 2026 in Review

Ascent Group reduced its Novartis (NVS) stake by 3.7% in Q2 2026, selling an estimated $73K and leaving 12,806 shares worth $2.01M. The position accounts for 0.06% of the portfolio, ranked #267.

Ascent Group first reported a position in NVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.03M in Q1 2026. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Ascent Group held 12,806 shares of Novartis worth $2.01M as of Q2 2026.
  • Ascent Group sold 487 Novartis shares in Q2 2026, an estimated $73K.
  • Novartis made up 0.06% of Ascent Group's portfolio in Q2 2026, its #267 holding.
  • Ascent Group first reported a position in Novartis in Q4 2021 and has held it in 19 quarters since.
  • Ascent Group's Novartis position peaked at $2.03M in Q1 2026.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.